Key result
Medical therapy extends survival up to ~2400 days in juvenile rabbits with dilated cardiomyopathy.
Why the study?
Dilated cardiomyopathy phenotype is rarely reported in juvenile pet rabbits, and its characteristics and outcomes are not well described.
Case Report (n=3)
Early diagnosis and long-term medical management of dilated cardiomyopathy phenotype in juvenile large-breed rabbits may result in longer lifespans than previously reported.
DCMph warrants consideration in juvenile large-breed rabbits with elevated ALT; extends sparse reports but leaves open prevalence and prognosis.
Background Dilated cardiomyopathy phenotype (DCMph) is rarely reported in juvenile pet rabbits ( Oryctolagus cuniculus ). Case description Three cases of DCMph in large-breed male rabbits <1 years of age (two intact, one castrated, weight range 3.3–3.8 kg at time of diagnosis) are described. All rabbits had non-specific or absent signs of disease on initial physical exam, but had elevations in alanine aminotransferase (ALT) above 130 U/L. Two of the cases were littermates that presented for routine castrations. The third case had a concurrent diagnosis of Eimeria (unspeciated). Diagnostic testing to investigate the ALT elevations was performed, and DCMph diagnoses were made via echocardiogram in each case. Medical management was initiated with a variety of treatments, including furosemide, enalapril, pimobendan, spironolactone, and nutraceutical supplements. One case was euthanized 283 days after DCMph diagnosis due to unrelated septicemia onset; the other two cases are alive at the time of publication (2444 days and 1743 days post diagnosis, respectively). Conclusions and clinical relevance This case series suggests a possible genetic etiology of DCMph in young, large breed rabbits, with a longer lifespan than previously reported in retrospective studies. Early diagnosis with long term-medical management may help improve outcomes.
No takes yet. Share an insight, caveat, or question.
McLaughlin et al. (2026) conducted a case report in Dilated cardiomyopathy phenotype (DCMph) (n=3). Medical management (furosemide, enalapril, pimobendan, spironolactone, nutraceuticals) was evaluated on Survival time. Medical management of dilated cardiomyopathy phenotype in three juvenile large-breed male rabbits resulted in extended survival times of 283, 1743, and 2444 days post-diagnosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: